- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 172479, 8 pages
Soluble Form of Canine Transferrin Receptor Inhibits Canine Parvovirus Infection In Vitro and In Vivo
1Laboratory of Molecular Virology and Immunology, College of Veterinary Medicine, Agricultural University of Hebei, Baodiing 071001, China
2Hebei Engineering and Technology Research Center of Veterinary Biological Products, North China Research Center of Animal Epidemic Pathogen Biology, China Agriculture Ministry, Baoding 071001, China
3Laboratory of Virology, College of Animal Science, Hebei Normal University of Science and Technology, Qinhuangdao 066600, China
4Cardinal Bernardin Cancer Center, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153, USA
5Department of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153, USA
6Department of Biotechnology, College of Environmental and Chemical Engineering, Yanshan University, Qinhuangdao 066004, China
Received 18 April 2013; Accepted 25 July 2013
Academic Editor: Lucia Lopalco
Copyright © 2013 Jiexia Wen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- G. W. Thomson and A. N. Gagnon, “Canine gastroenteritis associated with a parvovirus-like agent,” The Canadian Veterinary Journal, vol. 19, no. 12, pp. 346–364, 1978.
- C. R. Parrish, P. H. O'Connell, J. F. Evermann, and L. E. Carmichael, “Natural variation of canine parvovirus,” Science, vol. 230, no. 4729, pp. 1046–1048, 1985.
- N. Decaro and C. Buonavoglia, “Canine parvovirus—a review of epidemiological and diagnostic aspects, with emphasis on type 2c,” Veterinary Microbiology, vol. 155, no. 1, pp. 1–12, 2012.
- K. Hueffer, J. S. L. Parker, W. S. Weichert, R. E. Geisel, J.-Y. Sgro, and C. R. Parrish, “The natural host range shift and subsequent evolution of canine parvovirus resulted from virus-specific binding to the canine transferrin receptor,” Journal of Virology, vol. 77, no. 3, pp. 1718–1726, 2003.
- K. Hueffer, L. Govindasamy, M. Agbandje-McKenna, and C. R. Parrish, “Combinations of two capsid regions controlling canine host range determine canine transferrin receptor binding by canine and feline parvoviruses,” Journal of Virology, vol. 77, no. 18, pp. 10099–10105, 2003.
- J. S. L. Parker, W. J. Murphy, D. Wang, S. J. O'Brien, and C. R. Parrish, “Canine and feline parvoviruses can use human or feline transferrin receptors to bind, enter, and infect cells,” Journal of Virology, vol. 75, no. 8, pp. 3896–3902, 2001.
- K. Hueffer, L. M. Palermo, and C. R. Parrish, “Parvovirus infection of cells by using variants of the feline transferrin receptor altering clathrin-mediated endocytosis, membrane domain localization, and capsid-binding domains,” Journal of Virology, vol. 78, no. 11, pp. 5601–5611, 2004.
- C. M. Lawrence, S. Ray, M. Babyonyshev, R. Galluser, D. W. Borhani, and S. C. Harrison, “Crystal structure of the ectodomain of human transferrin receptor,” Science, vol. 286, no. 5440, pp. 779–782, 1999.
- A. N. Luck and A. B. Mason, “Transferrin-mediated cellular iron delivery,” Current Topics in Membranes, vol. 69, pp. 3–35, 2012.
- A. Ibricevic, A. Pekosz, M. J. Walter et al., “Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells,” Journal of Virology, vol. 80, no. 15, pp. 7469–7480, 2006.
- K. Vermeire, D. Schols, and T. W. Bell, “Inhibitors of HIV infection via the cellular CD4 receptor,” Current Medicinal Chemistry, vol. 13, no. 7, pp. 731–743, 2006.
- K. Vermeire and D. Schols, “Anti-HIV agents targeting the interaction of gp120 with the cellular CD4 receptor,” Expert Opinion on Investigational Drugs, vol. 14, no. 10, pp. 1199–1212, 2005.
- S. D. Marlin, D. E. Staunton, T. A. Springer, C. Stratowa, W. Sommergruber, and V. J. Merluzzi, “A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection,” Nature, vol. 344, no. 6261, pp. 70–72, 1990.
- S. Pöhlmann and R. W. Doms, “Evaluation of current approaches to inhibit HIV entry,” Current Drug Targets—Infectious Disorders, vol. 2, no. 1, pp. 9–16, 2002.
- K. M. Leung, D. X. Feng, J. Lou et al., “Development of human single-chain antibodies against SARS-associated coronavirus,” Intervirology, vol. 51, no. 3, pp. 173–181, 2008.
- P. Che, L. Wang, and Q. Li, “The development, optimization and validation of an assay for high throughput antiviral drug screening against dengue virus,” International Journal of Clinical and Experimental Medicine, vol. 2, no. 4, pp. 363–373, 2009.
- Q. Li, C. Maddox, L. Rasmussen, J. V. Hobrath, and L. E. White, “Assay development and high-throughput antiviral drug screening against Bluetongue virus,” Antiviral Research, vol. 83, no. 3, pp. 267–273, 2009.
- K. C. Deen, J. S. McDougal, R. Inacker et al., “A soluble form of CD4 (T4) protein inhibits AIDS virus infection,” Nature, vol. 331, no. 6151, pp. 82–84, 1988.
- W. Wang, X. Li, X. Wang, D. Han, S. Pan, and F. Zhong, “Establishment of CHO-K1 cell lines stably expressing canine parvovirus VP2 structure protein,” Chinese Journal of Veterinary Science, vol. 30, no. 5, pp. 588–592, 2010.
- W. Wang, X. Li, F. Zhong et al., “Secreting expression and characterization of canine parvovirus VP2 protein in eukaryotic cells,” Wei Sheng Wu Xue Bao, vol. 49, no. 5, pp. 648–652, 2009.
- H. Jin, F. Zhong, L. Wu, M. Xie, W. Wang, and D. Han, “Construction of eukaryotic expression vector carrying canine β-defensin-1 gene and its expression in HEK293T cells,” Current Zoology, vol. 54, no. 5, pp. 897–902, 2008.
- S. Pan, X. Li, F. Zhong, X. Wang, D. Han, and W. Wang, “Study on codon optimization and expression of canine sTfR gene in eukaryotic cells and interaction with canine parvovirus VP2 protein,” Chinese Journal of Veterinary Science, vol. 29, no. 12, pp. 1539–1543, 2009.
- A. I. Derman, W. A. Prinz, D. Belin, and J. Beckwith, “Mutations that allow disulfide bond formation in the cytoplasm of Escherichia coli,” Science, vol. 262, no. 5140, pp. 1744–1747, 1993.
- A. N. Zakhartchouk, S. Viswanathan, I. Moshynskyy, M. Petric, and L. A. Babiuk, “Optimization of a DNA vaccine against SARS,” DNA and Cell Biology, vol. 26, no. 10, pp. 721–726, 2007.
- L. M. Palermo, K. Hueffer, and C. R. Parrish, “Residues in the apical domain of the feline and canine transferrin receptors control host-specific binding and cell infection of canine and feline parvoviruses,” Journal of Virology, vol. 77, no. 16, pp. 8915–8923, 2003.